|
PRELIMINARY PROGRAM
as of January 2003
| THURSDAY, FEBRUARY 6TH,
2003 |
09:00 - 17:00
|
Pre-Congress training course
"Quality Management Systems in ART.'
Supported by an unrestricted educational grant from Serono
Symposia International |
17:00 - 18:45
|
Opening Ceremony - GnRH Analogues - Perspectives of the
Future
Chairmen:
J. Rivier, USA
B. Lunenfeld, Israel
|
| |
THE
CURRENT CLINICAL AND REGULATORY STATUS OF ABARELIX,A GNRH ANTAGONIST
FOR THE TREATMENT OF PROSTATE CANCER
M.B. Garnick,USA |
| |
ORALLY-ACTIVE,
NON-PEPTIDE GNRH ANTAGONISTS
S. Struthers, H. Pan, S. Yen, T. Chen, B. Campbell, G.
Reinhart, C. Chen, R. Jimenez, H. Bozigian, USA |
| |
TAK-013:
A NOVEL, POTENT, AND ORALLY ACTIVE NONPEPTIDE ANTAGONIST FOR
THE HUMAN GONADOTROPIN-RELEASING HORMONE RECEPTOR
S. Furuya, N. Suzuki, N. Cho, S. Sasaki, T. Imada, M.
Harada, T. Urushibara, S. Takekawa, A. Horinouchi, E. Clark,
H. Onda,
M. Boyce, M. Fujino, Japan |
| |
CONCLUSIONS
J. Rivier, USA |
19:00 - 20:30
 |
Get-Together Reception
Sponsored by Organon |
|
